Radiotherapy-induced bone deterioration is exacerbated in diabetic rats treated with streptozotocin

Detalhes bibliográficos
Autor(a) principal: Jiang,Maogang
Data de Publicação: 2021
Outros Autores: Ding,Yuanjun, Xu,Shiwei, Hao,Xiaoxia, Yang,Yongqing, Luo,Erping, Jing,Da, Yan,Zedong, Cai,Jing
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Medical and Biological Research
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2021001200610
Resumo: Following radiotherapy, patients have decreased bone mass and increased risk of fragility fractures. Diabetes mellitus (DM) is also reported to have detrimental effects on bone architecture and quality. However, no clinical or experimental study has systematically characterized the bone phenotype of the diabetic patients following radiotherapy. After one month of streptozotocin injection, three-month-old male rats were subjected to focal radiotherapy (8 Gy, twice, at days 1 and 3), and then bone mass, microarchitecture, and turnover as well as bone cell activities were evaluated at 2 months post-irradiation. Micro-computed tomography results demonstrated that DM rats exhibited greater deterioration in trabecular bone mass and microarchitecture following irradiation compared with the damage to bone structure induced by DM or radiotherapy. The serum biochemical, bone histomorphometric, and gene expression assays revealed that DM combined with radiotherapy showed lower bone formation rate, osteoblast number on bone surface, and expression of osteoblast-related markers (ALP, Runx2, Osx, and Col-1) compared with DM or irradiation alone. DM plus irradiation also caused higher bone resorption rate, osteoclast number on bone surface, and expression of osteoclast-specific markers (TRAP, cathepsin K, and calcitonin receptor) than DM or irradiation treatment alone. Moreover, lower osteocyte survival and higher expression of Sost and DKK1 genes (two negative modulators of Wnt signaling) were observed in rats with combined DM and radiotherapy. Together, these findings revealed a higher deterioration of the diabetic skeleton following radiotherapy, and emphasized the clinical importance of health maintenance.
id ABDC-1_f9109c56ab743a805c2af0a96fdb9280
oai_identifier_str oai:scielo:S0100-879X2021001200610
network_acronym_str ABDC-1
network_name_str Brazilian Journal of Medical and Biological Research
repository_id_str
spelling Radiotherapy-induced bone deterioration is exacerbated in diabetic rats treated with streptozotocinRadiotherapyDiabetes mellitus (DM)Bone lossOsteoblastsOsteocytesFollowing radiotherapy, patients have decreased bone mass and increased risk of fragility fractures. Diabetes mellitus (DM) is also reported to have detrimental effects on bone architecture and quality. However, no clinical or experimental study has systematically characterized the bone phenotype of the diabetic patients following radiotherapy. After one month of streptozotocin injection, three-month-old male rats were subjected to focal radiotherapy (8 Gy, twice, at days 1 and 3), and then bone mass, microarchitecture, and turnover as well as bone cell activities were evaluated at 2 months post-irradiation. Micro-computed tomography results demonstrated that DM rats exhibited greater deterioration in trabecular bone mass and microarchitecture following irradiation compared with the damage to bone structure induced by DM or radiotherapy. The serum biochemical, bone histomorphometric, and gene expression assays revealed that DM combined with radiotherapy showed lower bone formation rate, osteoblast number on bone surface, and expression of osteoblast-related markers (ALP, Runx2, Osx, and Col-1) compared with DM or irradiation alone. DM plus irradiation also caused higher bone resorption rate, osteoclast number on bone surface, and expression of osteoclast-specific markers (TRAP, cathepsin K, and calcitonin receptor) than DM or irradiation treatment alone. Moreover, lower osteocyte survival and higher expression of Sost and DKK1 genes (two negative modulators of Wnt signaling) were observed in rats with combined DM and radiotherapy. Together, these findings revealed a higher deterioration of the diabetic skeleton following radiotherapy, and emphasized the clinical importance of health maintenance.Associação Brasileira de Divulgação Científica2021-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2021001200610Brazilian Journal of Medical and Biological Research v.54 n.12 2021reponame:Brazilian Journal of Medical and Biological Researchinstname:Associação Brasileira de Divulgação Científica (ABDC)instacron:ABDC10.1590/1414-431x2021e11550info:eu-repo/semantics/openAccessJiang,MaogangDing,YuanjunXu,ShiweiHao,XiaoxiaYang,YongqingLuo,ErpingJing,DaYan,ZedongCai,Jingeng2021-10-26T00:00:00Zoai:scielo:S0100-879X2021001200610Revistahttps://www.bjournal.org/https://old.scielo.br/oai/scielo-oai.phpbjournal@terra.com.br||bjournal@terra.com.br1414-431X0100-879Xopendoar:2021-10-26T00:00Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)false
dc.title.none.fl_str_mv Radiotherapy-induced bone deterioration is exacerbated in diabetic rats treated with streptozotocin
title Radiotherapy-induced bone deterioration is exacerbated in diabetic rats treated with streptozotocin
spellingShingle Radiotherapy-induced bone deterioration is exacerbated in diabetic rats treated with streptozotocin
Jiang,Maogang
Radiotherapy
Diabetes mellitus (DM)
Bone loss
Osteoblasts
Osteocytes
title_short Radiotherapy-induced bone deterioration is exacerbated in diabetic rats treated with streptozotocin
title_full Radiotherapy-induced bone deterioration is exacerbated in diabetic rats treated with streptozotocin
title_fullStr Radiotherapy-induced bone deterioration is exacerbated in diabetic rats treated with streptozotocin
title_full_unstemmed Radiotherapy-induced bone deterioration is exacerbated in diabetic rats treated with streptozotocin
title_sort Radiotherapy-induced bone deterioration is exacerbated in diabetic rats treated with streptozotocin
author Jiang,Maogang
author_facet Jiang,Maogang
Ding,Yuanjun
Xu,Shiwei
Hao,Xiaoxia
Yang,Yongqing
Luo,Erping
Jing,Da
Yan,Zedong
Cai,Jing
author_role author
author2 Ding,Yuanjun
Xu,Shiwei
Hao,Xiaoxia
Yang,Yongqing
Luo,Erping
Jing,Da
Yan,Zedong
Cai,Jing
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Jiang,Maogang
Ding,Yuanjun
Xu,Shiwei
Hao,Xiaoxia
Yang,Yongqing
Luo,Erping
Jing,Da
Yan,Zedong
Cai,Jing
dc.subject.por.fl_str_mv Radiotherapy
Diabetes mellitus (DM)
Bone loss
Osteoblasts
Osteocytes
topic Radiotherapy
Diabetes mellitus (DM)
Bone loss
Osteoblasts
Osteocytes
description Following radiotherapy, patients have decreased bone mass and increased risk of fragility fractures. Diabetes mellitus (DM) is also reported to have detrimental effects on bone architecture and quality. However, no clinical or experimental study has systematically characterized the bone phenotype of the diabetic patients following radiotherapy. After one month of streptozotocin injection, three-month-old male rats were subjected to focal radiotherapy (8 Gy, twice, at days 1 and 3), and then bone mass, microarchitecture, and turnover as well as bone cell activities were evaluated at 2 months post-irradiation. Micro-computed tomography results demonstrated that DM rats exhibited greater deterioration in trabecular bone mass and microarchitecture following irradiation compared with the damage to bone structure induced by DM or radiotherapy. The serum biochemical, bone histomorphometric, and gene expression assays revealed that DM combined with radiotherapy showed lower bone formation rate, osteoblast number on bone surface, and expression of osteoblast-related markers (ALP, Runx2, Osx, and Col-1) compared with DM or irradiation alone. DM plus irradiation also caused higher bone resorption rate, osteoclast number on bone surface, and expression of osteoclast-specific markers (TRAP, cathepsin K, and calcitonin receptor) than DM or irradiation treatment alone. Moreover, lower osteocyte survival and higher expression of Sost and DKK1 genes (two negative modulators of Wnt signaling) were observed in rats with combined DM and radiotherapy. Together, these findings revealed a higher deterioration of the diabetic skeleton following radiotherapy, and emphasized the clinical importance of health maintenance.
publishDate 2021
dc.date.none.fl_str_mv 2021-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2021001200610
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2021001200610
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1414-431x2021e11550
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
dc.source.none.fl_str_mv Brazilian Journal of Medical and Biological Research v.54 n.12 2021
reponame:Brazilian Journal of Medical and Biological Research
instname:Associação Brasileira de Divulgação Científica (ABDC)
instacron:ABDC
instname_str Associação Brasileira de Divulgação Científica (ABDC)
instacron_str ABDC
institution ABDC
reponame_str Brazilian Journal of Medical and Biological Research
collection Brazilian Journal of Medical and Biological Research
repository.name.fl_str_mv Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)
repository.mail.fl_str_mv bjournal@terra.com.br||bjournal@terra.com.br
_version_ 1754302948860493824